4//SEC Filing
Ngo Nhat H 4
Accession 0001179110-20-001737
CIK 0000926326other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 2:38 PM ET
Size
9.6 KB
Accession
0001179110-20-001737
Insider Transaction Report
Form 4
OMNICELL, IncOMCL
Ngo Nhat H
VP, Strategy & Business Dev.
Transactions
- Award
Common Stock
2020-02-13+1,996→ 31,051 total - Award
Common Stock
2020-02-13+2,218→ 29,055 total - Award
Stock Options NQ (Right to Buy)
2020-02-13+8,537→ 8,537 totalExercise: $90.19From: 2021-02-13Exp: 2030-02-12→ Common Stock (8,537 underlying)
Holdings
- 26,837
Common Stock
Footnotes (3)
- [F1]The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2021 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2021 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance.
- [F2]RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years.
- [F3]NQ: Shares shall vest ratably over 48 month period, with a year cliff.
Documents
Issuer
OMNICELL, Inc
CIK 0000926326
Entity typeother
Related Parties
1- filerCIK 0001305020
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 2:38 PM ET
- Size
- 9.6 KB